North America Cancer Immunotherapy Market Size & Outlook

Name: North America Cancer Immunotherapy Market Size & Outlook
Creator: Grand View Research
License: https://www.grandviewresearch.com/horizon/info/terms-of-use

The cancer immunotherapy market in North America is expected to reach a projected revenue of US$ 124,762.5 million by 2033. A compound annual growth rate of 8.3% is expected of North America cancer immunotherapy market from 2026 to 2033.

Pharmaceuticals
- Oncology Drugs
  - Cancer Immunotherapy Market Outlook

North America cancer immunotherapy product outlook (Revenue, USD million, 2021-2033)
- Monoclonal Antibodies
- Check Point Inhibitors
- Oncolytic Viral Therapies and Cancer Vaccines
North America cancer immunotherapy application outlook (Revenue, USD million, 2021-2033)
- Lung Cancer
- Breast Cancer
- Colorectal Cancer
- Melanoma
- Prostate Cancer
- Head and Neck Cancer
- Ovarian Cancer
- Pancreatic Cancer
- Other Applications
North America cancer immunotherapy distribution channel outlook (Revenue, USD million, 2021-2033)
- Hospital Pharmacy
- Retail Pharmacy
- Online Pharmacy
North America cancer immunotherapy end use outlook (Revenue, USD million, 2021-2033)
- Hospitals and Clinics
- Cancer Research Centers
- Other End users

North America Cancer Immunotherapy Market Size & Outlook

Data Tree

Sign up - it's easy, and free!